Clinical trial
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian…
NCT00298233 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00298233 |
|---|---|
| Title | High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza |
| Official title | High-Dose Versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza: A Phase II Double-Blind, Randomized Clinical Trial |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Wellcome Trust World Health Organization University of Oxford |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza, Avian Influenza, Severe Influenza |
| Intervention type | Drug |
| Interventions | Oseltamivir |
| Enrollment | 326 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Mar 1, 2006 |
| Last update posted | Jun 6, 2014 |
| Countries | Singapore, Thailand, Vietnam |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: